Kohale, I.N.; Yu, J.; Zhuang, Y.; Fan, X.; Reddy, R.J.; Sinnwell, J.; Kalari, K.R.; Boughey, J.C.; Carter, J.M.; Goetz, M.P.;
et al. Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer. Cancers 2022, 14, 4220.
https://doi.org/10.3390/cancers14174220
AMA Style
Kohale IN, Yu J, Zhuang Y, Fan X, Reddy RJ, Sinnwell J, Kalari KR, Boughey JC, Carter JM, Goetz MP,
et al. Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer. Cancers. 2022; 14(17):4220.
https://doi.org/10.3390/cancers14174220
Chicago/Turabian Style
Kohale, Ishwar N., Jia Yu, Yongxian Zhuang, Xiaoyang Fan, Raven J. Reddy, Jason Sinnwell, Krishna R. Kalari, Judy C. Boughey, Jodi M. Carter, Matthew P. Goetz,
and et al. 2022. "Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer" Cancers 14, no. 17: 4220.
https://doi.org/10.3390/cancers14174220
APA Style
Kohale, I. N., Yu, J., Zhuang, Y., Fan, X., Reddy, R. J., Sinnwell, J., Kalari, K. R., Boughey, J. C., Carter, J. M., Goetz, M. P., Wang, L., & White, F. M.
(2022). Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer. Cancers, 14(17), 4220.
https://doi.org/10.3390/cancers14174220